Abstract
Based on their growth, tumors are classified into benign(compact) tumors and malignant (invasive) tumors. One of the treatments used for tumors is antiangiogenic therapy because this therapy has low toxicity. This study examines the effect of antiangiogenic therapy on compact tumors. The number of tumor cells changes over time are influenced by proliferation, death, and migration tumor cell. Antiangiogenic therapy can inhibit the process of angiogenesis which affect the dynamics of glucose flow. A lack of glucose flow will cause a decrease in tumor cell proliferation process which will decrease tumor growth rate. The finding suggests that maintaining glucose levels at or below a critical threshold is effective therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
